WNT inhibitor (JW Pharmaceutical)

N/A

Report date: 2025/03/20 09:51:57
NME

Base Information

Drug NameWNT inhibitor (JW Pharmaceutical)
Drug Alias NameProject A2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatenin beta 1 degraders
TargetsCatenin beta 1
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJw Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesJw Pharmaceutical Corp
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary FibrosisAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A